IL17A and head and neck squamous cell carcinoma: In 1,25(OH)2D3-treated HNSCC patients, the increases in levels of IL-17 resembled the increases seen for leptin, with a strong correlation in levels of these two mediators (Figure 3, right panel; r = 0.6336, p = 0.00039).